Mutation of NPM1 generally coincides with FLT3-ITD, DNMT3A or IDH1/2, leading to inferior recovery and OS in AML(Papaemmanuil et al., 2016; Dunlap et al., 2019). This evidence concerns the gene IDH1 and acute myeloid leukemia.